Chimeric Therapeutics Ltd. (CHM) Price & Analysis

Q: What was Chimeric Therapeutics Ltd.’s price range in the past 12 months?

Chimeric Therapeutics Ltd. lowest share price was <AU$0.01 and its highest was AU$0.04 in the past 12 months.

Q: What is Chimeric Therapeutics Ltd.’s market cap?

Chimeric Therapeutics Ltd.’s market cap is AU$12.75M.

Q: When is Chimeric Therapeutics Ltd.’s upcoming earnings report date?

Chimeric Therapeutics Ltd.’s upcoming earnings report date is Feb 26, 2026 which is in 69 days.

Q: How were Chimeric Therapeutics Ltd.’s earnings last quarter?

Chimeric Therapeutics Ltd. released its earnings results on Aug 29, 2025. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.004.

Q: Is Chimeric Therapeutics Ltd. overvalued?

According to Wall Street analysts Chimeric Therapeutics Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Chimeric Therapeutics Ltd. pay dividends?

Chimeric Therapeutics Ltd. does not currently pay dividends.

Q: What is Chimeric Therapeutics Ltd.’s EPS estimate?

Chimeric Therapeutics Ltd.’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Chimeric Therapeutics Ltd. have?

Chimeric Therapeutics Ltd. has 3,642,136,200 shares outstanding.

Q: What happened to Chimeric Therapeutics Ltd.’s price movement after its last earnings report?

Chimeric Therapeutics Ltd. reported an EPS of -AU$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Q: Which hedge fund is a major shareholder of Chimeric Therapeutics Ltd.?

Currently, no hedge funds are holding shares in AU:CHM

Compare

13 Followers

CHM Stock Chart & Stats

AU$0.01

AU$0.00(0.00%)

At close: Jan 09 4:00 PM EST

AU$0.01

AU$0.00(0.00%)

Day’s Range― - ―

52-Week Range<AU$0.01 - AU$0.04

Previous CloseN/A

Volume2.58M

Average Volume (3M)3.63M

Market Cap

AU$12.75M

Enterprise ValueAU$2.30M

Total Cash (Recent Filing)AU$5.76M

Total Debt (Recent Filing)AU$0.00

Price to Earnings (P/E)―

Beta2.27

Next Earnings

Feb 26, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding3,642,136,200

10 Day Avg. Volume3,014,500

30 Day Avg. Volume3,625,345

Financial Highlights & Ratios

PEG Ratio<0.01

Price to Book (P/B)2.74

Price to Sales (P/S)1.36

P/FCF Ratio-0.74

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Chimeric Therapeutics Ltd. News

Chimeric Therapeutics Grants 16.7 Million Unlisted Options to Director Miles Prince

An announcement from Chimeric Therapeutics Ltd. ( ($AU:CHM) ) is now available. Chimeric Therapeutics has disclosed a change...

2h ago

CHM

Chimeric Therapeutics Shares Halted Ahead of Material Capital Raising Announcement

Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has provided an announcement. Chimeric Therapeutics has requested and been granted a...

3h ago

CHM

Chimeric Therapeutics’ CHM 1107 Receives FDA Orphan Drug Designation for Gastric Cancer

The latest announcement is out from Chimeric Therapeutics Ltd. ( ($AU:CHM) ). Chimeric Therapeutics announced that its novel...

11d ago

CHM

Chimeric Therapeutics Announces Board Changes and Promising Trial Results

The latest update is out from Chimeric Therapeutics Ltd. ( ($AU:CHM) ). Chimeric Therapeutics announced significant board changes...

21d ago

CHM

Chimeric Therapeutics Announces Director Resignation

An update from Chimeric Therapeutics Ltd. ( ($AU:CHM) ) is now available. Chimeric Therapeutics Ltd. announced the resignation...

23d ago

CHM

Chimeric Therapeutics AGM Results and Leadership Changes

Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has provided an update. Chimeric Therapeutics Ltd. announced the results of its...

24d ago

CHM

Chimeric Therapeutics Highlights Risks in Clinical Trials and Regulatory Processes

Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has shared an update. Chimeric Therapeutics Ltd. has issued a news release...

24d ago

CHM

Chimeric Therapeutics Secures $4.5M R&D Tax Incentive to Boost Cancer Therapy Development

An announcement from Chimeric Therapeutics Ltd. ( ($AU:CHM) ) is now available. Chimeric Therapeutics has received a $4.5...

25d ago

CHM

Chimeric Therapeutics Reports Promising Results in CHM CDH17 Clinical Trial

An announcement from Chimeric Therapeutics Ltd. ( ($AU:CHM) ) is now available. Chimeric Therapeutics announced promising results from...

1M ago

CHM

Chimeric Therapeutics Temporarily Halts Phase 1b Trial Due to Supply Chain Issues

Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has issued an update. Chimeric Therapeutics has temporarily suspended its CHM CORE-NK...

1M ago

CHM

CHM FAQ

What was Chimeric Therapeutics Ltd.’s price range in the past 12 months?

Chimeric Therapeutics Ltd. lowest share price was <AU$0.01 and its highest was AU$0.04 in the past 12 months.

What is Chimeric Therapeutics Ltd.’s market cap?

Chimeric Therapeutics Ltd.’s market cap is AU$12.75M.

When is Chimeric Therapeutics Ltd.’s upcoming earnings report date?

Chimeric Therapeutics Ltd.’s upcoming earnings report date is Feb 26, 2026 which is in 69 days.

How were Chimeric Therapeutics Ltd.’s earnings last quarter?

Chimeric Therapeutics Ltd. released its earnings results on Aug 29, 2025. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.004.

Is Chimeric Therapeutics Ltd. overvalued?

According to Wall Street analysts Chimeric Therapeutics Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Chimeric Therapeutics Ltd. pay dividends?

Chimeric Therapeutics Ltd. does not currently pay dividends.

What is Chimeric Therapeutics Ltd.’s EPS estimate?

Chimeric Therapeutics Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Chimeric Therapeutics Ltd. have?

Chimeric Therapeutics Ltd. has 3,642,136,200 shares outstanding.

What happened to Chimeric Therapeutics Ltd.’s price movement after its last earnings report?

Chimeric Therapeutics Ltd. reported an EPS of -AU$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Chimeric Therapeutics Ltd.?

Currently, no hedge funds are holding shares in AU:CHM

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Chimeric Therapeutics Ltd. Stock Smart Score

Underperform

Blogger Sentiment

Bullish

AU:CHM Sentiment 80%
Sector Average 68%

Fundamentals

Return on Equity

-469.35%

Trailing 12-Months

Asset Growth

41.24%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Chimeric Therapeutics Ltd.

Chimeric Therapeutics Ltd. (CHM) is a biotechnology company focused on the development of novel cell therapies for cancer treatment. The company leverages its expertise in chimeric antigen receptor T-cell (CAR-T) technology to design and develop next-generation therapies aimed at improving patient outcomes. Chimeric Therapeutics is committed to pioneering advanced approaches in immunotherapy, with a pipeline of products targeting various cancer indications.